CELC
CELC
NASDAQ · Biotechnology

Celcuity Inc

$110.22
+8.21 (+8.05%)
As of Mar 25, 9:54 PM ET ·
Financial Highlights (FY 2025)
Revenue
856.50M
Net Income
-244,490,059
Gross Margin
41.9%
Profit Margin
-28.6%
Rev Growth
+6.2%
D/E Ratio
1.11
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 41.9% 41.9% 41.9%
Operating Margin -21.1% -21.9% -24.1%
Profit Margin -28.6% -25.3% -22.0%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 856.50M 842.65M 828.36M
Gross Profit 358.54M 352.74M 346.76M
Operating Income -180,791,334 -184,889,704 -199,659,598
Net Income -244,490,059 -213,463,076 -182,555,570
Gross Margin 41.9% 41.9% 41.9%
Operating Margin -21.1% -21.9% -24.1%
Profit Margin -28.6% -25.3% -22.0%
Rev Growth +6.2% -3.6% +12.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 2.19B 2.35B 2.55B
Total Equity 1.97B 2.12B 1.91B
D/E Ratio 1.11 1.11 1.34
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -292,781,484 -259,398,727 -297,826,578
Free Cash Flow -124,649,561 -156,876,378 -179,431,543